Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra(®), TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome

BACKGROUND: Ezatiostat hydrochloride liposomes for injection, a glutathione S-transferase P1-1 inhibitor, was evaluated in myelodysplastic syndrome (MDS). The objectives were to determine the safety, pharmacokinetics, and hematologic improvement (HI) rate. Phase 1-2a testing of ezatiostat for the tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Raza, Azra, Galili, Naomi, Callander, Natalie, Ochoa, Leonel, Piro, Lawrence, Emanuel, Peter, Williams, Stephanie, Burris, Howard, Faderl, Stefan, Estrov, Zeev, Curtin, Peter, Larson, Richard A, Keck, James G, Jones, Marsha, Meng, Lisa, Brown, Gail L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694211/
https://www.ncbi.nlm.nih.gov/pubmed/19439093
http://dx.doi.org/10.1186/1756-8722-2-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694211/
https://www.ncbi.nlm.nih.gov/pubmed/19439093
http://dx.doi.org/10.1186/1756-8722-2-20

Ejemplares similares